Randolph C. Read, Director at ENZON PHARMACEUTICALS, INC. (ENZN), bought 99,550 shares at $0.14 ($14K) on 2023-06-16, disclosed to the SEC on 2023-06-16.
Open-market purchase of $14k ENZN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.13 | 15,000 | $2K | 14.1% |
| 2 | $0.14 | 84,550 | $12K | 85.9% |
| Total | $0.14 avg | 99,550 | $14K | 100% |
| Filing → |